SwingTrade Member Forum

[MikeDDKing]

Remember that RX.V is a company that basically did this earnings ramp on one drug. They just started selling the second drug, the third drug just received regulatory approval, and there are two additional drugs that should be selling in a year or so. Therefore, in the time of say 15-18 months they will have gone from one drug to five drugs! The earnings growth for RX.V, IMO, is going to continue its insane run for at least the next two years and probably more. Therefore, I think this stock deserves a much higher multiple than you have given it. Also, I expect earnings next quarter to be $0.04/share pre-tax which is higher than you seem to estimate in this post. I think RX.V could be a $5 stock in a few years but it certainly will have swings along the way.

Besides, your analysis when you sold RX.V at $0.81 was a little off so why should we listen to you now?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=79590542